Clinical trials
Phase 2 Liver Cirrhosis trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 3 |
| AstraZeneca | 2 |
| Gilead Sciences | 2 |
| Jules Bordet Institute | 1 |
| Novartis Pharmaceuticals | 1 |
| Tobira Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Cirrhosis | 10 |
| Ascites | 3 |
| Non-alcoholic Fatty Liver Disease | 3 |
| Carcinoma, Hepatocellular | 1 |
| Cholangitis, Sclerosing | 1 |
| Fatty Liver | 1 |
| Fibrosis | 1 |
| Hyponatremia | 1 |
| Liver Diseases | 1 |
| Liver Neoplasms | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.